208 related articles for article (PubMed ID: 36766705)
1. Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription.
Oelschläger L; Stahl P; Kaschani F; Stauber RH; Knauer SK; Hensel A
Cells; 2023 Jan; 12(3):. PubMed ID: 36766705
[TBL] [Abstract][Full Text] [Related]
2. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells.
Bier C; Hecht R; Kunst L; Scheiding S; Wünsch D; Goesswein D; Schneider G; Krämer OH; Knauer SK; Stauber RH
PLoS One; 2012; 7(5):e34142. PubMed ID: 22570686
[TBL] [Abstract][Full Text] [Related]
4. Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo.
Bier C; Knauer SK; Wünsch D; Kunst L; Scheiding S; Kaiser M; Ottmann C; Krämer OH; Stauber RH
FASEB J; 2012 Aug; 26(8):3421-9. PubMed ID: 22623586
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks.
Williamson LM; Lees-Miller SP
Carcinogenesis; 2011 Mar; 32(3):279-85. PubMed ID: 21112959
[TBL] [Abstract][Full Text] [Related]
6. Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors.
Knauer SK; Fetz V; Rabenstein J; Friedl S; Hofmann B; Sabiani S; Schröder E; Kunst L; Proschak E; Thines E; Kindler T; Schneider G; Marschalek R; Stauber RH; Bier C
PLoS One; 2011; 6(5):e18253. PubMed ID: 21647428
[TBL] [Abstract][Full Text] [Related]
7. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
[TBL] [Abstract][Full Text] [Related]
8. The Roles of DNA Topoisomerase IIβ in Transcription.
Madabhushi R
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966298
[TBL] [Abstract][Full Text] [Related]
9. Etoposide quinone is a covalent poison of human topoisomerase IIβ.
Smith NA; Byl JA; Mercer SL; Deweese JE; Osheroff N
Biochemistry; 2014 May; 53(19):3229-36. PubMed ID: 24766193
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia.
Zhao Z; Wang L; Volk AG; Birch NW; Stoltz KL; Bartom ET; Marshall SA; Rendleman EJ; Nestler CM; Shilati J; Schiltz GE; Crispino JD; Shilatifard A
Genes Dev; 2019 Jan; 33(1-2):61-74. PubMed ID: 30573454
[TBL] [Abstract][Full Text] [Related]
11. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.
Hsieh JJ; Cheng EH; Korsmeyer SJ
Cell; 2003 Oct; 115(3):293-303. PubMed ID: 14636557
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
13. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.
Sabiani S; Geppert T; Engelbrecht C; Kowarz E; Schneider G; Marschalek R
EBioMedicine; 2015 May; 2(5):386-95. PubMed ID: 26137584
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
[TBL] [Abstract][Full Text] [Related]
16. The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.
Gilroy KL; Austin CA
PLoS One; 2011 Feb; 6(2):e14693. PubMed ID: 21358820
[TBL] [Abstract][Full Text] [Related]
17. The importin-alpha/nucleophosmin switch controls taspase1 protease function.
Bier C; Knauer SK; Docter D; Schneider G; Krämer OH; Stauber RH
Traffic; 2011 Jun; 12(6):703-14. PubMed ID: 21418451
[TBL] [Abstract][Full Text] [Related]
18. DNA Double-Strand Breaks Are a Critical Regulator of Fear Memory Reconsolidation.
Navabpour S; Rogers J; McFadden T; Jarome TJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256213
[TBL] [Abstract][Full Text] [Related]
19. Stimulated activity of human topoisomerases IIalpha and IIbeta on RNA-containing substrates.
Wang Y; Knudsen BR; Bjergbaek L; Westergaard O; Andersen AH
J Biol Chem; 1999 Aug; 274(32):22839-46. PubMed ID: 10428869
[TBL] [Abstract][Full Text] [Related]
20. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
